Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 1/20 | 0.46 |
| ▸ | MEN1 | O00255 | 2/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.42 |
| ▸ | METAP2 | P50579 | 1/20 | 0.40 |
| ▸ | NPC1 | O15118 | 1/20 | 0.40 |
| ▸ | RAB9A | P51151 | 1/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.37 |
| ▸ | BCHE | P06276 | 1/20 | 0.36 |
| ▸ | HPGD | P15428 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6448274 | 0.86 | EPHX1 (0.45) | EPHX1MEN1KMT2ANPC1RAB9A | |
| SCHEMBL6450220 | 0.76 | POLB (0.38) | EPHX1MEN1KMT2A | |
| SCHEMBL8392277 | 0.75 | EPHX1 (0.59) | EPHX1NPC1RAB9AL3MBTL1SIGMAR1 | |
| SCHEMBL931424 | 0.75 | EPHX1 (0.59) | EPHX1NPC1RAB9AL3MBTL1SIGMAR1 | |
| SCHEMBL6447033 | 0.74 | EPHX1 (0.44) | EPHX1MEN1KMT2ANPC1RAB9A | |
| SCHEMBL6448452 | 0.73 | EPHX1 (0.36) | EPHX1MEN1KMT2AL3MBTL1HPGD | |
| SCHEMBL6448447 | 0.73 | EPHX1 (0.36) | EPHX1MEN1KMT2AL3MBTL1HPGD | |
| SCHEMBL6707040 | 0.73 | EPHX1 (0.56) | EPHX1NPC1RAB9AL3MBTL1SIGMAR1 | |
| SCHEMBL6446725 | 0.72 | TDP1 (0.36) | MEN1KMT2A | |
| SCHEMBL629852 | 0.72 | EPHX1 (0.56) | EPHX1MEN1KMT2ANPC1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6921832-B2 | Optically active fluorine-containing compounds and processes for their production | TOSOH CORPORATION (JP) | 2005-07-26 | — | — | US | disclosed |
| US-20040147756-A1 | Optically active fluorine-containing compounds and processes for their production | TOSOH CORPORATION (JP) | 2004-07-29 | — | — | US | disclosed |
| EP-1422226-A1 | Optically active fluorine-containing compounds and processes for their production | Tosoh Corporation (JP) | 2004-05-26 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040147756-A1 | Optically active fluorine-containing compounds and processes for their production | CYP2C19, CYP2F1, CYP2B6 | EPHX1 1735/4885MEN1 1070/4885KMT2A 1059/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.